About this Research Topic
Cannabis species (Cannabis spp.) are pharmacologically diverse plants containing myriad distinct compounds, with the two endocannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) as prime examples. In humans, the use of cannabis-derived products is increasing globally. Veterinary medicine is dovetailing this trend with growing interest from clients and veterinarians for treating medical conditions in animals with these molecules. In general, CBD is the primary entity of interest in veterinary medicine. While cannabinoids show considerable therapeutic potential in the management of osteoarthritis, epilepsy, pain, and other conditions, there is currently a paucity of adequately controlled studies and data to confirm the safe and effective use in these indications. This research topic aims to consolidate recent findings and results of high-quality research on the safety and efficacy of cannabis derivatives in animal species. This, in turn, will serve as a basis for further discussions and investigations in this growing therapeutic area.
This research topic aims to consolidate recent findings and results of high-quality research on the safety and efficacy of cannabis derivatives in animal species. This, in turn, will serve as a basis for further discussions and investigations in this growing therapeutic area. The primary objectives include addressing specific questions about the therapeutic use of cannabinoids in animals, testing hypotheses related to their pharmacokinetics and pharmacodynamics, and evaluating the safety of chronic cannabinoid administration. By answering these questions, the research aims to fill the existing gaps and provide a more comprehensive understanding of the potential benefits and risks associated with cannabis derivatives in veterinary medicine.
To gather further insights into the use of cannabis derivatives in veterinary medicine, we welcome articles addressing, but not limited to, the following themes:
- Therapeutic use of cannabinoids in animals
- Pharmacokinetic investigations of cannabis derivatives
- In vivo / in vitro pharmacodynamic studies of molecules associated with cannabis
- Cannabis-related intoxications of animals
- Safety of chronic cannabinoid administration in animals
This research topic aims to consolidate recent findings and results of high-quality research on the safety and efficacy of cannabis derivatives in animal species. This, in turn, will serve as a basis for further discussions and investigations in this growing therapeutic area. The primary objectives include addressing specific questions about the therapeutic use of cannabinoids in animals, testing hypotheses related to their pharmacokinetics and pharmacodynamics, and evaluating the safety of chronic cannabinoid administration. By answering these questions, the research aims to fill the existing gaps and provide a more comprehensive understanding of the potential benefits and risks associated with cannabis derivatives in veterinary medicine.
To gather further insights into the use of cannabis derivatives in veterinary medicine, we welcome articles addressing, but not limited to, the following themes:
- Therapeutic use of cannabinoids in animals
- Pharmacokinetic investigations of cannabis derivatives
- In vivo / in vitro pharmacodynamic studies of molecules associated with cannabis
- Cannabis-related intoxications of animals
- Safety of chronic cannabinoid administration in animals
Keywords: Cannabinoids, cannabidiol, dog, cat, horse, epilepsy, osteoarthritis, pain
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
